WASHINGTON — The Trump administration announces that it is cancelling approximately $766 million in funding to Moderna regarding its human H5N1 avian influenza vaccine.
The previous Biden administration had awarded Moderna $590 million in January for a bird flu vaccine. This is in addition to about $176 million last year from the U.S. Department of Health and Human Services for the development and testing of a mRNA pre-pandemic bird flu vaccine.
The HHS says that this research no longer meets its scientific and safety standards.
“After a rigorous review, we concluded that continued investment in Moderna’s. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
